查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1946396

植物干细胞市场－全球产业规模、份额、趋势、机会及预测（按地区、应用、区域和竞争格局划分，2021-2031年）

Plant Stem Cell Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Location, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球植物干细胞市场预计将从 2025 年的 4.1412 亿美元成长到 2031 年的 6.8351 亿美元，复合年增长率为 8.71%。

这些干细胞是从植物分生组织中提取的未分化细胞，在受控的实验室环境中培养，用于生产製药和化妆品行业所需的特定生物活性化合物。该领域的成长主要源自于对兼具卓越纯度和效力，同时又能保护自然生物多样性的永续成分日益增长的需求。此外，製造商正积极采用这项技术，以确保原料的稳定性和供应链的稳定，而这些因素使得传统的田间种植作物更容易受到气候变迁的影响。

市场概览
预测期 2027-2031
市场规模：2025年 4.1412亿美元
市场规模：2031年 6.8351亿美元
复合年增长率：2026-2031年 8.71%
成长最快的细分市场 化妆品
最大的市场 北美洲

生物技术的应用正受到日益壮大的认证天然成分网路的推动。 NATRUE 2024年的数据显示，全球约有10,000种产品和成分带有NATRUE标籤，这表明标准化天然成分的商业性框架已相当稳固。然而，生技基础设施所需的高额资本投入仍是市场扩张的一大障碍。建造和扩大生物反应器系统的成本巨大，可能会限制盈利，因此，这项技术的应用往往主要局限于高级产品领域。

市场驱动因素

全球对活肤和抗衰老产品的需求日益增长，是推动植物干细胞技术应用的主要动力。消费者倾向于选择能带来实际效果（例如增加肌肤密度和减少皱纹）的高效配方，因此各大品牌纷纷转向以强大抗氧化特性着称的分生组织细胞培养技术。这种对功效的商业性需求也反映在小众成分开发商的财务表现上。例如，Vytrus Biotech在2024年4月发布的2024年第一季财报中显示，其全球销售额成长了32%，并将这一成长主要归功于欧美护肤市场的復苏。

同时，对环保和永续采购的重视正在改变工业实践，生物技术为传统收割方式提供了一种资源高效的替代方案。利用生物反应器，製造商可以在不耗尽稀有植物物种或占用大片耕地的情况下生产稳定的生物活性成分，从而帮助大型企业实现其严格的环境目标。欧莱雅等业界领导者便是这股趋势的典范。欧莱雅在其2024年3月发布的2023年度报告中重点强调了其向可再生原材料的转型，并指出其65%的成分为生物基成分。此外，根据英国美容协会于2024年8月发布的《2024年美容价值报告》，预计2023年个人护理业将为英国GDP贡献272亿英镑，为先进的化妆品解决方案提供强劲的经济基础。

市场挑战

全球植物干细胞市场成长的主要障碍在于生物技术基础设施所需的大量资本投入。生物反应器系统的开发和规模化建设需要大量的前期投资和持续的营运成本，这直接推高了最终原材料的价格。这种经济模式迫使植物干细胞化合物维持在高价位，从而有效地阻碍了它们在大众市场化妆品中的应用，而成本效益和微薄的利润率在这些领域至关重要。

因此，市场规模成长受到限制，因为中小企业往往缺乏足够的财力来采用这项技术或购买如此高价值的原料。该行业的资源密集型特性也造成了很高的进入门槛。根据2024年欧洲化妆品协会的数据，欧洲化妆品产业在研发方面的投资约为23亿欧元，这凸显了支持此类先进创新所需的资本密集环境。这种高额的资本需求限制了市场参与者的数量，使这项技术只能作为小众产品，并阻碍了其在更广泛的产品类型中的商业性应用。

市场趋势

头皮护理和毛囊再生领域的拓展标誌着市场关注点显着超越了脸部美容。供应商正在调整最初用于改善皮肤密度的植物细胞培养技术，以靶向毛囊讯号通路和维持生长期的微生物群。这一被称为「护髮护肤品的皮肤化」的趋势，正促使品牌将高价值的生物技术活性成分融入精华液和洗髮精中，以满足消费者对治疗头髮稀疏和脱髮症的临床级效果的需求。欧洲化妆品协会于2025年6月发布的《2024年市场表现报告》强调了该领域的商业性潜力，报告显示，欧洲护髮市场增长5.6%，零售额达到181亿欧元，凸显了功能性成分整合的盈利潜力。

同时，人工智慧在活性成分分析和发现领域的应用，正在改变製造商检测和提炼植物干细胞中强效植物化学物质的方式。机器学习模型和预测演算法取代了传统的试验误法，用于绘製细胞培养代谢组图谱，使研究人员能够在规模化生产之前识别出具有特定保护或表观遗传功能的稀有化合物。这种数位化提高了功效声明的准确性，并显着缩短了新型生物活性成分的研发前置作业时间。主要企业的支出趋势也反映了这个策略转变。欧莱雅于2025年3月发布的2024年度报告显示，公司在研发和创新方面的投资超过13亿欧元，强调了人工智慧与绿色科学的融合将加速先进美容解决方案的发展。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球植物干细胞市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依位置（茎尖分生组织、根尖分生组织、维管分生组织）
    • 依用途（营养、药品、化妆品）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章 北美植物干细胞市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 我们
    • 加拿大
    • 墨西哥

7. 欧洲植物干细胞市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

8. 亚太地区植物干细胞市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

9. 中东和非洲植物干细胞市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲植物干细胞市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章 全球植物干细胞市场：SWOT分析

第十四章 波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Uniliver PLC
  • Renature Skin Care Inc.
  • PhytoScience Ltd.
  • Oriflame Cosmetics AG
  • MyChelle Dermaceuticals LLC
  • Mibelle Group AG
  • Juice Beauty LLC
  • Emsland Group GmbH
  • Bio-FD&C Co., Ltd.
  • Aidan Products LLC

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 17262

The Global Plant Stem Cell Market is projected to expand from USD 414.12 Million in 2025 to USD 683.51 Million by 2031, reflecting a CAGR of 8.71%. These stem cells, which are undifferentiated cells obtained from plant meristematic tissue, are cultivated in controlled laboratory settings to produce specific bioactive compounds for the pharmaceutical and cosmetic industries. Growth in this sector is largely propelled by the rising demand for sustainable ingredients that provide exceptional purity and potency while protecting natural biodiversity. Additionally, manufacturers are increasingly embracing this technology to guarantee ingredient consistency and supply chain stability, factors often compromised by climatic fluctuations in traditional field-grown crops.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 414.12 Million
Market Size 2031USD 683.51 Million
CAGR 2026-20318.71%
Fastest Growing SegmentCosmetics
Largest MarketNorth America

This transition toward biotechnology is bolstered by an expanding network of certified natural inputs, evidenced by NATRUE's 2024 data showing nearly 10,000 products and raw materials bearing the NATRUE Label globally, signaling a robust commercial framework for standardized natural ingredients. However, the high capital expenditure necessary for biotechnological infrastructure remains a substantial obstacle to wider market growth. The significant costs associated with establishing and scaling bioreactor systems can constrain profitability, thereby limiting the adoption of this technology primarily to premium product tiers.

Market Driver

The increasing global demand for skin rejuvenation and anti-aging products serves as a major driver for the integration of plant stem cell technology. As consumers prioritize high-performance formulations that offer tangible improvements in skin density and wrinkle reduction, brands are turning to meristematic cell cultures recognized for their potent antioxidant capabilities. This commercial demand for efficacy is reflected in the financial performance of niche ingredient developers; for instance, Vytrus Biotech reported a 32% global sales increase in its Q1 2024 results released in April 2024, a surge attributed largely to the rebounding skincare markets in Europe and the United States.

Concurrently, the focus on eco-friendly and sustainable ingredient sourcing is transforming industrial methods, with biotechnology providing a resource-efficient substitute for traditional harvesting. By utilizing bioreactors, manufacturers can generate consistent bioactive ingredients without exhausting rare plant species or occupying extensive arable land, meeting the strict environmental goals of large conglomerates. This trend is illustrated by industry leaders like L'Oreal, which noted in its March 2024 '2023 Annual Report' that 65% of its raw materials were bio-based, highlighting the shift to renewable inputs. Furthermore, the British Beauty Council's 'Value of Beauty Report 2024', published in August 2024, revealed that the personal care sector added £27.2 billion to the UK GDP in 2023, indicating a strong economic backdrop for advanced cosmetic solutions.

Market Challenge

A major hurdle to the growth of the Global Plant Stem Cell Market is the significant capital expenditure needed for biotechnological infrastructure. The development and scaling of bioreactor systems entail substantial upfront investment and continuous operational costs, which directly increase the final price of the produced ingredients. This economic framework forces plant stem cell compounds to remain within the premium price bracket, effectively blocking their inclusion in mass-market cosmetic products where cost efficiency and tight profit margins are critical.

As a result, the market experiences limited volume growth because small and medium-sized enterprises frequently lack the financial capacity to implement this technology or acquire such high-value inputs. The resource-intensive nature of this industry establishes a high entry barrier; according to Cosmetics Europe data from 2024, the European industry poured roughly 2.3 billion euros into research and development, highlighting the capital-heavy environment needed to support such advanced innovation. This elevated financial requirement restricts the number of market players and keeps the technology as a niche offering, impeding its widespread commercial application across broader product categories.

Market Trends

The expansion into scalp care and hair follicle regeneration marks a significant broadening of the market's focus beyond facial aesthetics. Suppliers are increasingly adapting plant cell cultures, initially designed for skin density, to target the signaling pathways and microbiota of hair follicles responsible for maintaining the anagen phase. This trend, often referred to as the "skinification" of hair care, meets consumer demand for clinical-level efficacy in addressing thinning hair and alopecia, encouraging brands to add high-value biotech actives to serums and shampoos. The sector's commercial potential is highlighted by Cosmetics Europe's 'Market Performance 2024' report from June 2025, which notes that the European hair care category expanded by 5.6% to a retail value of 18.1 billion euros, offering a profitable path for functional ingredient integration.

Simultaneously, the incorporation of AI into the profiling and discovery of active ingredients is transforming how manufacturers detect and refine potent phytochemicals in plant stem cells. Replacing traditional trial-and-error methods, machine learning models and predictive algorithms are now employed to map cell culture metabolomes, enabling researchers to identify rare compounds with specific protective or epigenetic functions prior to physical scaling. This digitization improves the accuracy of efficacy claims and drastically shortens the lead time for introducing new bio-actives. Major corporate spending reflects this strategic pivot; L'Oreal's '2024 Annual Report' from March 2025 indicates an investment of over 1.3 billion euros in Research & Innovation, emphasizing the fusion of artificial intelligence and green sciences to expedite the development of advanced beauty solutions.

Key Market Players

  • Uniliver PLC
  • Renature Skin Care Inc.
  • PhytoScience Ltd.
  • Oriflame Cosmetics AG
  • MyChelle Dermaceuticals LLC
  • Mibelle Group AG
  • Juice Beauty LLC
  • Emsland Group GmbH
  • Bio-FD&C Co., Ltd.
  • Aidan Products LLC

Report Scope

In this report, the Global Plant Stem Cell Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Plant Stem Cell Market, By Location

  • Shoot Apical Meristems
  • Root Apical Meristems
  • Vascular Meristems

Plant Stem Cell Market, By Application

  • Nutrition
  • Pharmaceutical
  • and Cosmetics

Plant Stem Cell Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Plant Stem Cell Market.

Available Customizations:

Global Plant Stem Cell Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Plant Stem Cell Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Location (Shoot Apical Meristems, Root Apical Meristems, Vascular Meristems)
    • 5.2.2. By Application (Nutrition, Pharmaceutical, and Cosmetics)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Plant Stem Cell Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Location
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Plant Stem Cell Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Location
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Plant Stem Cell Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Location
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Plant Stem Cell Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Location
        • 6.3.3.2.2. By Application

7. Europe Plant Stem Cell Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Location
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Plant Stem Cell Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Location
        • 7.3.1.2.2. By Application
    • 7.3.2. France Plant Stem Cell Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Location
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Plant Stem Cell Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Location
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Plant Stem Cell Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Location
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Plant Stem Cell Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Location
        • 7.3.5.2.2. By Application

8. Asia Pacific Plant Stem Cell Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Location
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Plant Stem Cell Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Location
        • 8.3.1.2.2. By Application
    • 8.3.2. India Plant Stem Cell Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Location
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Plant Stem Cell Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Location
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Plant Stem Cell Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Location
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Plant Stem Cell Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Location
        • 8.3.5.2.2. By Application

9. Middle East & Africa Plant Stem Cell Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Location
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Plant Stem Cell Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Location
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Plant Stem Cell Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Location
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Plant Stem Cell Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Location
        • 9.3.3.2.2. By Application

10. South America Plant Stem Cell Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Location
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Plant Stem Cell Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Location
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Plant Stem Cell Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Location
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Plant Stem Cell Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Location
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Plant Stem Cell Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Uniliver PLC
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Renature Skin Care Inc.
  • 15.3. PhytoScience Ltd.
  • 15.4. Oriflame Cosmetics AG
  • 15.5. MyChelle Dermaceuticals LLC
  • 15.6. Mibelle Group AG
  • 15.7. Juice Beauty LLC
  • 15.8. Emsland Group GmbH
  • 15.9. Bio-FD&C Co., Ltd.
  • 15.10. Aidan Products LLC

16. Strategic Recommendations

17. About Us & Disclaimer